As you know, you are employed by XOMA Corporation (the “Company”) pursuant to the terms of an Officer Employment Agreement dated August 7, 2017, as amended on April 1, 2022 (the “Agreement”). You and the Company are hereby agreeing to amend the...Officer Employment Agreement • March 9th, 2023 • XOMA Corp • Pharmaceutical preparations
This Amendment forms the complete and exclusive agreement between you and the Company with respect to this subject matter. It supersedes any other agreements or promises made to you by anyone, whether oral or written, with respect to such subject matter. Changes to the terms of this Amendment require a written modification signed by an officer of the Company. This Amendment may be delivered and executed via facsimile, electronic mail (including pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act or other applicable law) or other transmission method and shall be deemed to have been duly and validly delivered and executed and be valid and effective for all purposes.
OFFICER EMPLOYMENT AGREEMENTOfficer Employment Agreement • March 9th, 2023 • XOMA Corp • Pharmaceutical preparations • California
This Officer Employment Agreement (“Agreement”) between Bradley Sitko (“Employee”) and XOMA Corporation (“XOMA” or “the Company”) (collectively, the “Parties”) is effective as of January 3, 2023 (the “Agreement Effective Date”).
IP ACQUISITION AGREEMENTIp Acquisition Agreement • March 9th, 2023 • XOMA Corp • Pharmaceutical preparations • New York
This IP ACQUISITION AGREEMENT (this “Agreement”), dated as of November 21, 2022 (the “Effective Date”), is made by and between OBSEVA, SA, a Swiss corporation having its principal place of business at Chemin des Aulx, 12, 1228 Plan-les-Ouates, Geneva, Switzerland (“Seller”), and XOMA (US) LLC, a Delaware limited liability company having its principal place of business at 2200 Powell Street, Suite 310, Emeryville, CA 94608 (“Buyer”).
LICENSE AGREEMENTLicense Agreement • March 9th, 2023 • XOMA Corp • Pharmaceutical preparations
This License Agreement (the “Agreement”) is dated as of June 10, 2015 (the “Effective Date”) by and between Ares Trading SA, a Swiss corporation with registered offices at Zone Industrielle de l’Ouriettaz, 1108 Aubonne, Switzerland (“Merck Serono”) and Obseva S.A., a Swiss corporation with registered offices at 12, Chemin des Aulx, 1228 Plan-Les-Ouates, Geneva (“Licensee”). Merck Serono and Licensee may be referred to herein as a “Party” or, collectively, as “Parties”.
LICENSE AGREEMENT (EBOPIPRANT)License Agreement • March 9th, 2023 • XOMA Corp • Pharmaceutical preparations • New York
This License Agreement (the “Agreement”) is entered into as of July 26, 2021 (the “Effective Date”), by and between ObsEva SA, having an address at Chemin des Aulx 12, 1228 Plan-Les-Ouates, Switzerland (“ObsEva”) and Organon International GmbH, having an address at Weystrasse 20, 6006 Lucerne, Switzerland (“Organon”). ObsEva and Organon may be referred to herein individually as a “Party” or collectively as the “Parties.”
OFFICER EMPLOYMENT AGREEMENTOfficer Employment Agreement • March 9th, 2023 • XOMA Corp • Pharmaceutical preparations • California
This Officer Employment Agreement (“Agreement”) between Owen Hughes (“Employee”) and XOMA Corporation (“XOMA” or “the Company”) (collectively, the “Parties”) is effective as of January 1, 2023 (the “Agreement Effective Date”).
